Hap Trading, LLC Capricor Therapeutics, Inc. Call Options Transaction History

Hap Trading, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$3.36 - $6.55 $13,104 - $25,545	-3,900 Reduced 23.49%	12,700 $8,000
Q3 2022 Nov 14, 2022	BUY	$3.61 - $6.08 $59,926 - $100,928	16,600 New	16,600 $25,000
Q4 2021 Feb 14, 2022	SELL	$2.89 - $4.16 $11,560 - $16,640	-4,000 Reduced 16.06%	20,900 $4,000
Q3 2021 Nov 10, 2021	BUY	$3.8 - $5.23 $14,440 - $19,874	3,800 Added 18.01%	24,900 $22,000
Q2 2021 Aug 11, 2021	SELL	$3.16 - $5.72 $18,328 - $33,176	-5,800 Reduced 21.56%	21,100 $36,000
Q1 2021 May 14, 2021	BUY	$3.63 - $7.93 $22,143 - $48,373	6,100 Added 29.33%	26,900 $32,000
Q4 2020 Feb 16, 2021	SELL	$3.43 - $5.23 $10,290 - $15,690	-3,000 Reduced 12.61%	20,800 $22,000
Q3 2020 Nov 13, 2020	BUY	$4.08 - $9.81 $97,104 - $233,478	23,800 New	23,800 $25,000

8.2M

1.78M

1.4M

Ticker CAPR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,346,200
Market Cap $372M
Description
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.